PAQ Therapeutics is a biotechnology company pioneering a new approach to restoring health and curing disease through autophagy.
PAQ Therapeutics has raised $38.0M in total funding. The most recent round was Series B. The last funding was announced in January 2026.
PAQ Therapeutics's investors include Matrix Partners China, Sherpa Healthcare Partners, Johnson & Johnson Innovation, Huagai Capital, MRL Ventures Fund.
PAQ Therapeutics is headquartered in Cambridge, United States.
PAQ Therapeutics is a biotechnology company pioneering a new approach to restoring health and curing disease through autophagy.
PAQ Therapeutics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PAQ Therapeutics — Funding & Investors." VCBacked, January 22, 2026, https://www.vcbacked.co/company/paq-therapeutics. Accessed July 20, 2026.
VCBacked. (2026). PAQ Therapeutics — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/paq-therapeutics
{{cite web |title=PAQ Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/paq-therapeutics |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated